Cyclosporin (Sandoz)

What it is used for

Cyclosporin Sandoz is indicated as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. For induction and/or maintenance of remission in the nephrotic syndrome. Cyclosporin is not a first-line agent. Its use should be restricted to occasions when steroids and cytostatic drugs have failed, or are not tolerated, or are considered inappropriate, and when renal function is unimpaired (see Precautions). For the treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting antirheumatic agents (including methotrexate) are inappropriate or ineffective. In patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate and the disease has caused a significant interference with the quality of life. For the treatment of severe atopic dermatitis when other treatment is ineffective or inappropriate. Careful monitoring of all cyclosporin-treated patients is mandatory. Cyclosporin should only be used by medical practitioners who are experienced in the use of immunosuppressive therapy (see “Precautions”).